BMC Pregnancy and Childbirth (Sep 2009)

Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial)

  • Scherjon Sicco A,
  • Lotgering Fred K,
  • van Pampus Maria G,
  • Opmeer Brent C,
  • Kwee Anneke,
  • van Eyck Jim,
  • Duvekot Johannes J,
  • Derks Jan B,
  • Cornette Jérôme,
  • Bolte Annemiek C,
  • Bloemenkamp Kitty WM,
  • Scheepers Hubertina CJ,
  • Porath Martina M,
  • Oudijk Martijn A,
  • Wilms Femke F,
  • Vis Jolande Y,
  • Sollie Krystyna M,
  • Spaanderman Marc EA,
  • Willekes Christine,
  • van der Post Joris AM,
  • Mol Ben

DOI
https://doi.org/10.1186/1471-2393-9-38
Journal volume & issue
Vol. 9, no. 1
p. 38

Abstract

Read online

Abstract Background At present, women with threatened preterm labor before 32 weeks of gestation are, after transfer to a perinatal center, treated with tocolytics and corticosteroids. Many of these women are treated unnecessarily. Fibronectin is an accurate predictor for the occurrence of preterm birth among women with threatened preterm labor. We will assess whether triage of these women with fibronectin testing, cervical length or their combination is cost-effective. Methods/Design We will investigate a prospective cohort of women referred to a perinatal centre for spontaneous threatened preterm labor between 24 and 34 weeks with intact membranes. All women will be tested for fibronectin and cervical length. Women with a cervical length 30 mm will be managed according to local protocol. Corticosteroids may be given to all women at the discretion of the attending physician. Primary outcome measure will be delivery within 7 days. Secondary outcome measures will be neonatal morbidity and mortality, complications of tocolytics, costs and health related quality of life. The analysis will be according to the intention to treat principle. We anticipate the probability on preterm birth within 7 days in the group of women with a negative fibronectine test to be 5%. Two groups of 110 women will be needed to assure that in case of non-inferiority the difference in the proportion of preterm deliveries Discussion This study will provide evidence for the use of fibronectin testing as safe and cost-effective method in a triage for threatened preterm labor. Trial registration Nederlands Trial Register (NTR) number 1857, http://www.trialregister.nl.